Literature DB >> 17516924

Melanoma invasion - current knowledge and future directions.

Cedric Gaggioli1, Erik Sahai.   

Abstract

The acquisition of invasive behaviour is the key transition in the progression of benign melanocyte hyperplasia to life threatening melanoma. Understanding this transition and the mechanisms of invasion are the key to understanding why malignant melanoma is such a devastating disease and will aid treatment strategies. Underlying the invasive behaviour is increased cell motility caused by changes in cytoskeletal organization and altered contacts with the extra-cellular matrix (ECM). In addition, changes in the interactions of melanoma cells with keratinocytes and fibroblasts enable them to survive and proliferate outside their normal epidermal location. Proteomic and genomic initiatives are greatly increasing our knowledge of which gene products are deregulated in invasive and metastatic melanoma; however, the next challenge is to understand how these genes promote the invasion of melanoma cells. In recent years new models have been developed that more closely recapitulate the conditions of melanoma invasion in vivo. It is hoped that these models will give us a better understanding of how the genes implicated in melanoma progression affect the motility of melanoma cells and their interactions with the ECM, stromal cells and blood vessels. This review will summarise our current understanding of melanoma invasion and focus on the new model systems that can be used to study melanoma.

Entities:  

Mesh:

Year:  2007        PMID: 17516924     DOI: 10.1111/j.1600-0749.2007.00378.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  45 in total

1.  Elevated cyclic AMP levels promote BRAFCA/Pten-/- mouse melanoma growth but pCREB is negatively correlated with human melanoma progression.

Authors:  Carlos I Rodríguez; Edgardo Castro-Pérez; B Jack Longley; Vijayasaradhi Setaluri
Journal:  Cancer Lett       Date:  2017-11-24       Impact factor: 8.679

2.  Mechanically guided cell migration: less of a stretch than ever.

Authors:  Guy M Genin; Elliot L Elson
Journal:  Biophys J       Date:  2014-02-18       Impact factor: 4.033

Review 3.  Periostin in the pathogenesis of skin diseases.

Authors:  Hiroyuki Murota; Yang Lingli; Ichiro Katayama
Journal:  Cell Mol Life Sci       Date:  2017-09-15       Impact factor: 9.261

Review 4.  Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.

Authors:  Ross L Pearlman; Mary Katherine Montes de Oca; Harish Chandra Pal; Farrukh Afaq
Journal:  Cancer Lett       Date:  2017-01-25       Impact factor: 8.679

5.  Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study.

Authors:  Chi-Ping Day; John Carter; Carrie Bonomi; Dominic Esposito; Bruce Crise; Betty Ortiz-Conde; Melinda Hollingshead; Glenn Merlino
Journal:  Pigment Cell Melanoma Res       Date:  2009-01-19       Impact factor: 4.693

6.  Targeted deactivation of cancer-associated fibroblasts by β-catenin ablation suppresses melanoma growth.

Authors:  Linli Zhou; Kun Yang; R Randall Wickett; Ana Luisa Kadekaro; Yuhang Zhang
Journal:  Tumour Biol       Date:  2016-08-29

Review 7.  Profiling distinct mechanisms of tumour invasion for drug discovery: imaging adhesion, signalling and matrix turnover.

Authors:  Neil O Carragher
Journal:  Clin Exp Metastasis       Date:  2008-10-29       Impact factor: 5.150

8.  RhoJ modulates melanoma invasion by altering actin cytoskeletal dynamics.

Authors:  Hsiang Ho; Amelia Soto Hopkin; Rubina Kapadia; Priya Vasudeva; Jonathan Schilling; Anand K Ganesan
Journal:  Pigment Cell Melanoma Res       Date:  2013-01-07       Impact factor: 4.693

9.  A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants.

Authors:  Amaury Vaysse; Shenying Fang; Myriam Brossard; Qingyi Wei; Wei V Chen; Hamida Mohamdi; Lynda Vincent-Fetita; Patricia Margaritte-Jeannin; Nolwenn Lavielle; Eve Maubec; Mark Lathrop; Marie-Françoise Avril; Christopher I Amos; Jeffrey E Lee; Florence Demenais
Journal:  Int J Cancer       Date:  2016-07-23       Impact factor: 7.396

10.  Organotypic modelling as a means of investigating epithelial-stromal interactions during tumourigenesis.

Authors:  Athina-Myrto Chioni; Richard Grose
Journal:  Fibrogenesis Tissue Repair       Date:  2008-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.